Biovie Inc Stock Alpha and Beta Analysis

BIVI Stock  USD 3.05  0.06  1.93%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Biovie Inc. It also helps investors analyze the systematic and unsystematic risks associated with investing in Biovie over a specified time horizon. Remember, high Biovie's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Biovie's market risk premium analysis include:
Beta
0.11
Alpha
1.04
Risk
16.92
Sharpe Ratio
0.0735
Expected Return
1.24
Please note that although Biovie alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Biovie did 1.04  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Biovie Inc stock's relative risk over its benchmark. Biovie Inc has a beta of 0.11  . As returns on the market increase, Biovie's returns are expected to increase less than the market. However, during the bear market, the loss of holding Biovie is expected to be smaller as well. As of now, Biovie's Book Value Per Share is decreasing as compared to previous years. The Biovie's current Tangible Book Value Per Share is estimated to increase to 3.43, while Enterprise Value Over EBITDA is forecasted to increase to (0.03).
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Biovie Backtesting, Biovie Valuation, Biovie Correlation, Biovie Hype Analysis, Biovie Volatility, Biovie History and analyze Biovie Performance.

Biovie Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Biovie market risk premium is the additional return an investor will receive from holding Biovie long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Biovie. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Biovie's performance over market.
α1.04   β0.11

Biovie expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Biovie's Buy-and-hold return. Our buy-and-hold chart shows how Biovie performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Biovie Market Price Analysis

Market price analysis indicators help investors to evaluate how Biovie stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Biovie shares will generate the highest return on investment. By understating and applying Biovie stock market price indicators, traders can identify Biovie position entry and exit signals to maximize returns.

Biovie Return and Market Media

The median price of Biovie for the period between Sun, Aug 25, 2024 and Sat, Nov 23, 2024 is 2.74 with a coefficient of variation of 33.5. The daily time series for the period is distributed with a sample standard deviation of 0.81, arithmetic mean of 2.42, and mean deviation of 0.68. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
BioVie Secures All Scientific Approvals Needed to Receive Additional 12.6 Million of Grant Funding to Launch Planned Phase 2 Trial to Evaluate Bezisterim in Lon...
09/16/2024
2
Why BioVie Stock Is Down Over 50 percent Today
09/24/2024
3
12 Health Care Stocks Moving In Thursdays After-Market Session - Benzinga
09/26/2024
4
BioVie and Genetic Technologies Interviews to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TV
10/11/2024
5
BioVie Inc. Announces Pricing of Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
10/21/2024
6
Disposition of 1000 shares by Adams Jonathan M of Biovie subject to Rule 16b-3
10/23/2024
7
BioVie Inc. Announces Pricing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
10/28/2024
8
Acquisition by Berman Richard J of 51830 shares of Biovie subject to Rule 16b-3
11/07/2024
9
BioVie files to sell 7.71M shares of common stock for holders
11/21/2024

About Biovie Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Biovie or other stocks. Alpha measures the amount that position in Biovie Inc has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.

Biovie Upcoming Company Events

As portrayed in its financial statements, the presentation of Biovie's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Biovie's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Biovie's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Biovie. Please utilize our Beneish M Score to check the likelihood of Biovie's management manipulating its earnings.
9th of February 2024
Upcoming Quarterly Report
View
10th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
21st of August 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
30th of June 2023
Last Financial Announcement
View

Build Portfolio with Biovie

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Biovie Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biovie's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biovie Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biovie Inc Stock:
Check out Biovie Backtesting, Biovie Valuation, Biovie Correlation, Biovie Hype Analysis, Biovie Volatility, Biovie History and analyze Biovie Performance.
You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Biovie technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Biovie technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Biovie trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...